NewsRoom Articles - Page 1309 of 1423

TuesdayMar 14, 2017 11:00 am

OSI Systems, Inc. (NASDAQ: OSIS) Starts Presentation at 29th Annual Roth Conference

OSI Systems (NASDAQ: OSIS) designs, manufactures and sells electronic systems and components worldwide. The company’s security segment provides baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation detection, and explosive and narcotics trace detection systems under the Rapiscan Systems name. This segment also offers site design, installation, training, and technical support services; and turnkey security screening solutions under the S2 name. Its Healthcare segment provides patient monitoring, diagnostic cardiology, anesthesia delivery and ventilation systems, defibrillators, and related supplies and accessories under the Spacelabs, Primedic, and Statcorp Medical names for use in critical care, emergency, and…

TuesdayMar 14, 2017 11:00 am

Crius Energy Trust (CRIUF) Starts Presentation at 29th Annual ROTH Conference

Crius Energy (OTC: CRIUF) is one of the largest independent energy retailers in the United States, providing electricity, natural gas and solar products to more than 950,000 residential and commercial customers. The company connects with energy customers through an innovative family-of-brands strategy and multi-channel marketing approach. The result is a broad, well-differentiated platform that minimizes risk while providing customers with unique and customized brand experiences. For more information, visit the company’s website at www.criusenergy.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news…

TuesdayMar 14, 2017 11:00 am

Akari Therapeutics Plc (NASDAQ: AKTX) Starts Presentation at 29th Annual ROTH Conference

Akari Therapeutics (NASDAQ: AKTX) is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal hemoglobinuria, Guillain Barre syndrome and atypical Hemolytic Uremic Syndrome. Its lead drug, Coversin, a complement inhibitor, acts on complement C5, preventing release of C5a and formation of C5b-9. The company is currently conducting a phase Ib clinical trial of Coversin. For more information, visit the company’s website at www.akaritx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

TuesdayMar 14, 2017 11:00 am

Spartan Motors, Inc. (NASDAQ: SPAR) Starts Presentation at 29th Annual Roth Conference

Spartan Motors (NASDAQ: SPAR) engineers, manufactures and sells heavy-duty and custom vehicles in the United States, Canada, South America and Asia. The Emergency Response Vehicles segment offers emergency response chassis and bodies, and aerial ladder components. The Delivery and Service Vehicles segment provides walk-in vans for use in the package delivery, one-way truck rental, bakery/snack delivery, utility and linen/uniform rental businesses; and commercial truck bodies, as well as interior equipment up fitting and aftermarket parts. The Specialty Chassis and Vehicles segment offers motor home chassis, defense vehicles, and other specialty chassis, as well as distributes related aftermarket parts and assemblies.…

TuesdayMar 14, 2017 11:00 am

BIOLASE, Inc. (NASDAQ: BIOL) Starts Presentation at 29th Annual ROTH Conference

BIOLASE (NASDAQ: BIOL) is a medical device company that develops, manufactures and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company’s dental laser systems allow dentists, periodontists, endodontists, oral surgeons and other dental specialists to perform a range of dental procedures, including cosmetic, restorative, and complex surgical applications. For more information, visit the company’s website at www.biolase.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

TuesdayMar 14, 2017 10:41 am

India Globalization Capital, Inc. (NYSE: IGC) is “One to Watch”

India Globalization Capital, Inc. (NYSE MKT: IGC) is a first mover in developing a portfolio of products using cannabis-based “combination therapies” for the treatment of pain and other conditions. The national cost of health care due to pain ranges from $560 billion to $635 billion. In addition, the health care cost attributed to the abuse of prescription opioids, closely related to pain, is approximately $25 billion. IGC’s patent filing (IGC-501) is a cannabis-based formulation addressing neuropathic and arthritic pain in joints and muscles using a variety of delivery techniques. The Company anticipates commencing clinical trials, and hopes that through its…

TuesdayMar 14, 2017 10:30 am

Reis, Inc. (NASDAQ: REIS) Starts Presentation at 29th Annual Roth Conference

Reis (NASDAQ: REIS) provides commercial real estate market information and analytical tools to real estate professionals in the United States. It maintains a proprietary database containing information on commercial properties, including apartment, office, retail, warehouse/distribution, flex/research and development, self-storage plus senior and student housing properties in metropolitan markets and neighborhoods. The company’s data is used by real estate investors, lenders, and other professionals to make informed buying, selling, and financing decisions, plus debt and equity investors to assess, quantify, and manage the risks of default and loss associated with individual mortgages, properties, portfolios and real estate backed securities. For more…

TuesdayMar 14, 2017 10:30 am

Broadwind Energy, Inc. (NASDAQ: BWEN) Starts Presentation at 29th Annual ROTH Conference

Broadwind Energy (NASDAQ: BWEN) provides components and gearing as well as other specialized applications for customers in the clean tech, energy and infrastructure markets. The company is a precision manufacturer of these structures, equipment and components. With facilities throughout the U.S., the company is committed to helping customers maximize performance of their investments in a quicker, easier and smarter way. For more information, visit the company’s website at www.bwen.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an…

TuesdayMar 14, 2017 10:30 am

Neogen Corp. (NASDAQ: NEOG) Starts Presentation at 29th Annual Roth Conference

Neogen (NASDAQ: NEOG) develops, manufactures and markets various products and services for food and animal safety worldwide. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed. The Animal Safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products, and genetic testing services to the animal safety market. Its products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi and viruses. For more information, visit the company’s website at www.neogen.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication,…

TuesdayMar 14, 2017 10:30 am

Vascular Biogenics Ltd. (NASDAQ: VBLT) Starts Presentation at 29th Annual Roth Conference

Vascular Biogenics (NASDAQ: VBLT), operating as VBL Therapeutics, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer. The company’s lead oncology product candidate, ofranergene obadenovec (VB-111), is a first-in-class, targeted anti-cancer gene-therapy agent that is positioned to treat a wide range of solid tumors. It is conveniently administered as an IV infusion once every two months. It has been observed to be well-tolerated in >200 cancer patients and we have observed its efficacy signals in an “all comers” phase 1 trial as well as in three tumor-specific phase 2 studies. Ofranergene obadenovec…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

OSI Systems, Inc. (NASDAQ: OSIS) Starts Presentation at 29th Annual Roth Conference

Crius Energy Trust (CRIUF) Starts Presentation at 29th Annual ROTH Conference

Akari Therapeutics Plc (NASDAQ: AKTX) Starts Presentation at 29th Annual ROTH Conference

Spartan Motors, Inc. (NASDAQ: SPAR) Starts Presentation at 29th Annual Roth Conference

BIOLASE, Inc. (NASDAQ: BIOL) Starts Presentation at 29th Annual ROTH Conference

India Globalization Capital, Inc. (NYSE: IGC) is “One to Watch”

Reis, Inc. (NASDAQ: REIS) Starts Presentation at 29th Annual Roth Conference

Broadwind Energy, Inc. (NASDAQ: BWEN) Starts Presentation at 29th Annual ROTH Conference

Neogen Corp. (NASDAQ: NEOG) Starts Presentation at 29th Annual Roth Conference

Vascular Biogenics Ltd. (NASDAQ: VBLT) Starts Presentation at 29th Annual Roth Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search